EUVIMEDEUVIMED entdecken
Crossref

Integrated computational and biological evaluations of newly synthesized thiadiazole-based VEGFR-2 inhibitors with targeted anti-breast cancer activity

Bshra A Alsfouk, Walid E Elgammal, Hazem Elkady, Hazem A Mahdy, Dalal Z Husein, Omar A Soliman, Abdelrahman A Abuelkhir, Ibrahim H Eissa, Eslam B Elkaeed, Ahmed M Metwaly

Naunyn-Schmiedeberg's Archives of Pharmacology · 2026-01 · 399 (1) · 953-975

DOI: 10.1007/s00210-025-04439-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 23.07.2025. Verfasst von Bshra A Alsfouk und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah bint Abdulrahman University, P.O. Box 84428, 11671, Riyadh, Saudi Arabia. Hauptthemen laut MEDLINE: Thiadiazoles, Vascular Endothelial Growth Factor Receptor-2, Antineoplastic Agents, Breast Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: Princess Nourah Bint Abdulrahman University, AlMaarefa University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThiadiazolesVascular Endothelial Growth Factor Receptor-2Antineoplastic AgentsBreast NeoplasmsProtein Kinase InhibitorsHumansMolecular Docking SimulationApoptosisFemaleCell ProliferationMCF-7 CellsCell Line, TumorMolecular Dynamics Simulation

Stichwörter der Autor:innen

In vitroBreast cancerMD SimulationsMolecular dockingThiadiazole derivativesVEGFR-2

Substanzen

ThiadiazolesVascular Endothelial Growth Factor Receptor-2Antineoplastic AgentsKDR protein, humanProtein Kinase Inhibitors

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah bint Abdulrahman University, P.O. Box 84428, 11671, Riyadh, Saudi Arabia.
  • Department of Chemistry, Faculty of Science, Al-Azhar University, Nasr City, Cairo, Egypt.
  • Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, 11884, Egypt.
  • Chemistry Department, Faculty of Science, New Valley University, El-Kharja, 72511, Egypt.
  • Department of Clinical Pharmacy, Alexandria University Main Teaching Hospital, Alexandria, Egypt.
  • Department of Human Genetics, Medical Research Institute, Alexandria University, Alexandria, Egypt.

Förderung

  • Princess Nourah Bint Abdulrahman University
  • AlMaarefa University

Zitieren

APA

Alsfouk, B. A., Elgammal, W. E., Elkady, H., Mahdy, H. A., Husein, D. Z., Soliman, O. A., Abuelkhir, A. A., Eissa, I. H., Elkaeed, E. B., & Metwaly, A. M. (2026). Integrated computational and biological evaluations of newly synthesized thiadiazole-based VEGFR-2 inhibitors with targeted anti-breast cancer activity. Naunyn-Schmiedeberg's Archives of Pharmacology, 399(1), 953-975. https://doi.org/10.1007/s00210-025-04439-7

Vancouver

Alsfouk BA, Elgammal WE, Elkady H, Mahdy HA, Husein DZ, Soliman OA, et al. Integrated computational and biological evaluations of newly synthesized thiadiazole-based VEGFR-2 inhibitors with targeted anti-breast cancer activity. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026;399(1):953-975. doi:10.1007/s00210-025-04439-7

BibTeX
@article{Alsfouk2026,
  author = {Alsfouk, Bshra A and Elgammal, Walid E and Elkady, Hazem and Mahdy, Hazem A and Husein, Dalal Z and Soliman, Omar A and Abuelkhir, Abdelrahman A and Eissa, Ibrahim H and Elkaeed, Eslam B and Metwaly, Ahmed M},
  title = {Integrated computational and biological evaluations of newly synthesized thiadiazole-based VEGFR-2 inhibitors with targeted anti-breast cancer activity},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2026},
  volume = {399},
  number = {1},
  pages = {953--975},
  doi = {10.1007/s00210-025-04439-7}
}
Kostenlos starten →